Inovio Stock Probability of Future Stock Price Finishing Over 1.83

INO
 Stock
  

USD 1.83  0.01  0.55%   

Inovio Pharmaceuticals' future price is the expected price of Inovio Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Inovio Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Inovio Pharmaceuticals Price to Book Value is quite stable at the moment as compared to the past year. The company's current Price to Book Value is estimated at 2.70. Price to Sales Ratio is expected to rise to 633.51 this year, although the value of Price to Earnings Ratio will most likely fall to (3.71) .
  
Inovio Pharmaceuticals' implied volatility is one of the determining factors in the pricing options written on Inovio Pharmaceuticals. Implied volatility approximates the future value of Inovio Pharmaceuticals based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Inovio Pharmaceuticals over a specific time period. For example, 2022-12-09 CALL at $2.0 is a CALL option contract on Inovio Pharmaceuticals' common stock with a strick price of 2.0 expiring on 2022-12-09. The contract was last traded on 2022-12-06 at 14:23:49 for $0.02 and, as of today, has 2 days remaining before the expiration. The option is currently trading at a bid price of $0.02, and an ask price of $0.03. The implied volatility as of the 7th of December is 156.9789. View All Inovio options

Closest to current price Inovio long CALL Option Payoff at Expiration

Please see Inovio Pharmaceuticals Backtesting, Inovio Pharmaceuticals Valuation, Inovio Pharmaceuticals Correlation, Inovio Pharmaceuticals Hype Analysis, Inovio Pharmaceuticals Volatility, Inovio Pharmaceuticals History as well as Inovio Pharmaceuticals Performance. Please specify Inovio Pharmaceuticals time horizon, a valid symbol (red box) and a target price (blue box) you would like Inovio Pharmaceuticals odds to be computed.

Inovio Pharmaceuticals Target Price Odds to finish over 1.83

The tendency of Inovio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1.83 90 days 1.83 
about 92.65
Based on a normal probability distribution, the odds of Inovio Pharmaceuticals to move above the current price in 90 days from now is about 92.65 (This Inovio Pharmaceuticals probability density function shows the probability of Inovio Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.83 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Inovio Pharmaceuticals will likely underperform. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Inovio Pharmaceuticals is significantly underperforming NYSE Composite.
   Inovio Pharmaceuticals Price Density   
       Price  

Predictive Modules for Inovio Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Inovio Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Inovio Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Inovio Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.091.867.00
Details
Intrinsic
Valuation
LowReal ValueHigh
0.244.739.87
Details
8 Analysts
Consensus
LowTarget PriceHigh
6.0013.6235.00
Details
Earnings
Estimates (6)
LowProjected EPSHigh
-1.32-1.26-1.14
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inovio Pharmaceuticals. Your research has to be compared to or analyzed against Inovio Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Inovio Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Inovio Pharmaceuticals.

Inovio Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Inovio Pharmaceuticals is not an exception. The market had few large corrections towards the Inovio Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Inovio Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Inovio Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-1.01
β
Beta against NYSE Composite1.83
σ
Overall volatility
0.20
Ir
Information ratio -0.2

Inovio Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Inovio Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Inovio Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Inovio Pharmaceuticals generated a negative expected return over the last 90 days
Inovio Pharmaceuticals may become a speculative penny stock
Inovio Pharmaceuticals has high historical volatility and very poor performance
The company reported the last year's revenue of 1.77 M. Reported Net Loss for the year was (303.66 M) with loss before taxes, overhead, and interest of (247.47 M).
Inovio Pharmaceuticals has about 348.13 M in cash with (215.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.4.
Inovio Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: INOVIO Provides an Update on Lassa Fever and MERS Programs - Marketscreener.com

Inovio Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Inovio Stock often depends not only on the future outlook of the current and potential Inovio Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Inovio Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding208829801.00
Cash And Short Term Investments401314718.00

Inovio Pharmaceuticals Technical Analysis

Inovio Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Inovio Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Inovio Pharmaceuticals. In general, you should focus on analyzing Inovio Stock price patterns and their correlations with different microeconomic environments and drivers.

Inovio Pharmaceuticals Predictive Forecast Models

Inovio Pharmaceuticals time-series forecasting models is one of many Inovio Pharmaceuticals' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Inovio Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Inovio Pharmaceuticals

Checking the ongoing alerts about Inovio Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Inovio Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Inovio Pharmaceuticals generated a negative expected return over the last 90 days
Inovio Pharmaceuticals may become a speculative penny stock
Inovio Pharmaceuticals has high historical volatility and very poor performance
The company reported the last year's revenue of 1.77 M. Reported Net Loss for the year was (303.66 M) with loss before taxes, overhead, and interest of (247.47 M).
Inovio Pharmaceuticals has about 348.13 M in cash with (215.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.4.
Inovio Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: INOVIO Provides an Update on Lassa Fever and MERS Programs - Marketscreener.com

Complementary Tools for analysis

When running Inovio Pharmaceuticals price analysis, check to measure Inovio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharmaceuticals is operating at the current time. Most of Inovio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Inovio Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inovio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Inovio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Is Inovio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
446.6 M
Quarterly Revenue Growth YOY
30.382
Return On Assets
(0.43) 
Return On Equity
(0.92) 
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Inovio Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.